← FDA Warning Letters

Missouri Analytical Laboratories Inc

FDA Warning Letter · 2021-10-12 · Division of Pharmaceutical Quality Operations III

Letter

Company
Missouri Analytical Laboratories Inc
Posted Date
2021-10-12
Letter Issue Date
2021-09-30
Issuing Office
Division of Pharmaceutical Quality Operations III

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown